Headlines

Moderna Inc. (MRNA) - Q4 2025 (USD): Revenue 678mln (exp. 635mln), EPS -2.11 (exp. -2.54)

Newsquawk Staff ·

Moderna Inc. (MRNA) - Q4 2025 (USD): Revenue 678mln (exp. 635mln), EPS -2.11 (exp. -2.54)

What it means

Moderna's Q4 2025 results show a revenue beat against expectations, which indicates stronger operational performance and could positively influence investor sentiment. The narrower EPS loss compared to expectations also suggests improved cost management or higher efficiency; however, the ongoing losses may still raise concerns regarding profitability moving forward. Overall, these results could bolster confidence in the biotechnology sector, but caution is warranted given the continued losses, affecting how the stock might react in conjunction with broader market conditions.

Related headlines